Collaborators & Research Support
We aim to provide a training and mentoring environment to help discover the potentials within each member of our team, to reach their best and to become the next generation of global experts.
Our research emphasizes four dimensions: 1) Innovation; 2) Communication; 3) Collaboration; 4) Translation.
Our core values are: 1) Passion; 2) Trust; 3) Teamwork; 4) Responsibility; 5) Service; 6) Openness; 7) Growth; 8) Achievement
We pursue interdisciplinary research towards enhanced quantitative nuclear medicine (radiomolecular) imaging (PET & SPECT). Coupled with our provincial molecular imaging and therapy program, we emphasize partnerships with other collaborators, clinical sites and industry, aiming to translate our image generation and analysis methods (including artificial intelligence) to state-of-the-art patient care and to impact quality of life. Our efforts include:
- Quantitative PET/CT imaging methods for enhanced diagnosis, prognosis and treatment response assessment of cancer patients
- Quantitative SPECT-based dosimetry in radiopharmaceutical therapies (RPTs) of cancer patients
- AI and Radiomics methods as applied to PET and SPECT imaging for improved assessment of cancer, including physician-in-the-loop AI solution development
- Building of theranostic digital twins (TDTs) for our cancer patients towards precision RPTs
- Virtual theranostic trials (VTTs) for optimization of theranostic imaging and RPTs
- Anthropomorphic digital and physical phantom studies for optimization of clinical PET & SPECT imaging protocols
- Advanced statistical image reconstruction and parametric image generation algorithms
- And more!